BACKGROUND: Dynamic hyperinflation of the lungs impairs exercise performance in chronic obstructive pulmonary disease (COPD). However, it is unclear which patients are affected by dynamic hyperinflation and how the respiratory muscles respond to the change in lung volume. METHODS: Using optoelectronic plethysmography, total and regional chest wall volumes were measured non-invasively in 20 stable patients with COPD (mean (SD) forced expiratory volume in 1 second 43.6 (11.6)% predicted) and dynamic hyperinflation was tracked breath by breath to test if this was the mechanism of exercise limitation. Resting ventilation, breathing pattern, symptoms, rib cage and abdominal volumes were recorded at rest and during symptom limited cycle ergometry. Pleural, abdominal, and transdiaphragmatic pressures were measured in eight patients. RESULTS: End expiratory chest wall volume increased by a mean (SE) of 592 (80) ml in 12 patients (hyperinflators) but decreased by 462 (103) ml in eight (euvolumics). During exercise, tidal volume increased in euvolumic patients by reducing end expiratory abdominal volume while in hyperinflators tidal volume increased by increasing end inspiratory abdominal and rib cage volumes. The maximal abdominal pressure was 22.1 (9.0) cm H(2)O in euvolumic patients and 7.6 (2.6) cm H(2)O in hyperinflators. Euvolumic patients were as breathless as hyperinflators but exercised for less time and reached lower maximum workloads (p<0.05) despite having better spirometric parameters and a greater expiratory flow reserve. CONCLUSIONS: Dynamic hyperinflation is not the only mechanism limiting exercise performance in patients with stable COPD. Accurate measurement of chest wall volume can identify the different patterns of respiratory muscle activation during exercise.
BACKGROUND: Dynamic hyperinflation of the lungs impairs exercise performance in chronic obstructive pulmonary disease (COPD). However, it is unclear which patients are affected by dynamic hyperinflation and how the respiratory muscles respond to the change in lung volume. METHODS: Using optoelectronic plethysmography, total and regional chest wall volumes were measured non-invasively in 20 stable patients with COPD (mean (SD) forced expiratory volume in 1 second 43.6 (11.6)% predicted) and dynamic hyperinflation was tracked breath by breath to test if this was the mechanism of exercise limitation. Resting ventilation, breathing pattern, symptoms, rib cage and abdominal volumes were recorded at rest and during symptom limited cycle ergometry. Pleural, abdominal, and transdiaphragmatic pressures were measured in eight patients. RESULTS: End expiratory chest wall volume increased by a mean (SE) of 592 (80) ml in 12 patients (hyperinflators) but decreased by 462 (103) ml in eight (euvolumics). During exercise, tidal volume increased in euvolumic patients by reducing end expiratory abdominal volume while in hyperinflators tidal volume increased by increasing end inspiratory abdominal and rib cage volumes. The maximal abdominal pressure was 22.1 (9.0) cm H(2)O in euvolumic patients and 7.6 (2.6) cm H(2)O in hyperinflators. Euvolumic patients were as breathless as hyperinflators but exercised for less time and reached lower maximum workloads (p<0.05) despite having better spirometric parameters and a greater expiratory flow reserve. CONCLUSIONS: Dynamic hyperinflation is not the only mechanism limiting exercise performance in patients with stable COPD. Accurate measurement of chest wall volume can identify the different patterns of respiratory muscle activation during exercise.
Authors: Iacopo Iandelli; Andrea Aliverti; Bengt Kayser; Raffaele Dellacà; Stephen J Cala; Roberto Duranti; Susan Kelly; Giorgio Scano; Pawel Sliwinski; Sheng Yan; Peter T Macklem; Antonio Pedotti Journal: J Appl Physiol (1985) Date: 2002-05
Authors: Andrea Aliverti; Iacopo Iandelli; Roberto Duranti; Stephen J Cala; Bengt Kayser; Susan Kelly; Gianni Misuri; Antonio Pedotti; Giorgio Scano; Pawel Sliwinski; Sheng Yan; Peter T Macklem Journal: J Appl Physiol (1985) Date: 2002-05
Authors: I Vogiatzis; O Georgiadou; S Golemati; A Aliverti; E Kosmas; E Kastanakis; N Geladas; A Koutsoukou; S Nanas; S Zakynthinos; C Roussos Journal: Thorax Date: 2005-06-17 Impact factor: 9.139
Authors: Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-05-05 Impact factor: 3.619
Authors: A Aliverti; R L Dellacà; P Lotti; S Bertini; R Duranti; G Scano; J Heyman; A Lo Mauro; A Pedotti; P T Macklem Journal: Eur J Appl Physiol Date: 2005-08-05 Impact factor: 3.078